Search

Author/Creator Bristow, Robert G

1. [18F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial. Issue 4 (22nd April 2020)

Authors:
Glicksman, Rachel M; Metser, Ur; Valliant, John; Chung, Peter W; Fleshner, Neil E; Bristow, Robert G; Green, David; Finelli, Antonio; Hamilton, Robert; Stanescu, Teodor; Hussey, Douglas; Catton, Charles; Gospodarowicz, Mary; Warde, Padraig; Bayley, Andrew; Breen, Stephen; Vines, Doug; Jaffray, Da...
Journal:
BMJ open
Issue:
Volume 10:Issue 4(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A polygenic two-hit hypothesis for prostate cancer. (5th January 2023)

Authors:
Houlahan, Kathleen E; Livingstone, Julie; Fox, Natalie S; Kurganovs, Natalie; Zhu, Helen; Sietsma Penington, Jocelyn; Jung, Chol-Hee; Yamaguchi, Takafumi N; Heisler, Lawrence E; Jovelin, Richard; Costello, Anthony J; Pope, Bernard J; Kishan, Amar U; Corcoran, Niall M; Bristow, Robert G; Waszak, S...
Journal:
Journal of the National Cancer Institute
Issue:
Volume 115:Number 4(2023)
Page Start:
468
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinoma. (3rd July 2020)

Authors:
Armstrong, Chris W D; Coulter, Jonathan A; Ong, Chee Wee; Maxwell, Pamela J; Walker, Steven; Butterworth, Karl T; Lyubomska, Oksana; Berlingeri, Silvia; Gallagher, Rebecca; O'Sullivan, Joe M; Jain, Suneil; Mills, Ian G; Prise, Kevin M; Bristow, Robert G; LaBonte, Melissa J; Waugh, David J J
Journal:
NAR cancer
Issue:
Volume 2:Number 3(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology. Issue 5 (May 2018)

Authors:
Bristow, Robert G; Alexander, Brian; Baumann, Michael; Bratman, Scott V; Brown, J Martin; Camphausen, Kevin; Choyke, Peter; Citrin, Deborah; Contessa, Joseph N; Dicker, Adam; Kirsch, David G; Krause, Mechthild; Le, Quynh-Thu; Milosevic, Michael; Morris, Zachary S; Sarkaria, Jann N; Sondel, Paul M...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 5(2018)
Page Start:
e240
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. RadBone: bone toxicity following pelvic radiotherapy – a prospective randomised controlled feasibility study evaluating a musculoskeletal health package in women with gynaecological cancers undergoing pelvic radiotherapy. Issue 6 (14th June 2022)

Authors:
Chatzimavridou Grigoriadou, Victoria; Barraclough, Lisa H; Baricevic-Jones, Ivona; Bristow, Robert G; Eden, Martin; Haslett, Kate; Johnson, Karen; Kochhar, Rohit; Merchant, Zoe; Moore, John; O'Connell, Sarah; Taylor, Sally; Westwood, Thomas; Whetton, Anthony David; Yorke, Janelle; Higham, Claire E
Journal:
BMJ open
Issue:
Volume 12:Issue 6(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Temporal Stability and Prognostic Biomarker Potential of the Prostate Cancer Urine miRNA Transcriptome. (4th June 2019)

Authors:
Jeon, Jouhyun; Olkhov-Mitsel, Ekaterina; Xie, Honglei; Yao, Cindy Q; Zhao, Fang; Jahangiri, Sahar; Cuizon, Carmelle; Scarcello, Seville; Jeyapala, Renu; Watson, John D; Fraser, Michael; Ray, Jessica; Commisso, Kristina; Loblaw, Andrew; Fleshner, Neil E; Bristow, Robert G; Downes, Michelle; Vespri...
Journal:
Journal of the National Cancer Institute
Issue:
Volume 112:Number 3(2020)
Page Start:
247
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗